Committee Opinion No. 659: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer
The DOI matches its Crossref record.
Abstract
© 2016 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- Rippy, 2006, Is HRT justified for symptom management in women at higher risk of developing breast cancer C, limacteric, 9, 404, 10.1080/13697130601022367 · DOI
- 2004, Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society., Menopause, 11, 11, 10.1097/01.GME.0000108177.85442.71 · DOI · Paper page
- 2014, Practice Bulletin No. 141. American College of Obstetricians and Gynecologists., Obstet Gynecol, 123, 202
- Goetsch, 2014, Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial., Obstet Gynecol, 123, 1231, 10.1097/AOG.0000000000000283 · DOI
- Loprinzi, 1997, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM Jr, et al.. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer., J Clin Oncol, 15, 969, 10.1200/JCO.1997.15.3.969 · DOI · Paper page
- 2012, Committee Opinion No. 532. American College of Obstetricians and Gynecologists., Obstet Gynecol, 120, 411
- Lasley, 2002, . The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity., J Clin Endocrinol Metab, 87, 3760, 10.1210/jcem.87.8.8741 · doi:10.1210/jcem.87.8.8741 · Paper page
- Schmidt, 1994, Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation., Gynecol Obstet Invest, 38, 253, 10.1159/000292492 · DOI
- Mitchell, 2000, Three stages of the menopausal transition from the Seattle Midlife Womens Health Study: toward a more precise definition., Menopause, 7, 334, 10.1097/00042192-200007050-00008 · DOI · Paper page
- Wills, 2012, . Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator., J Oncol Pract, 8, 144, 10.1200/JOP.2011.000352 · DOI
- Rigg, 1978, Absorption of estrogens from vaginal creams., N Engl J Med, 298, 195, 10.1056/NEJM197801262980406 · DOI · Paper page
- Pschera, 1989, Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women., Gynecol Obstet Invest, 27, 204, 10.1159/000293657 · DOI
- Santen, 2002, . Treatment of urogenital atrophy with low-dose estradiol: preliminary results., Menopause, 9, 179, 10.1097/00042192-200205000-00006 · DOI
- Simunic, 2003, Local estrogen treatment in patients with urogenital symptoms., Int J Gynaecol Obstet, 82, 187, 10.1016/S0020-7292(03)00200-5 · DOI
- Ponzone, 2005, Vaginal oestrogen therapy after breast cancer: is it safe Eur J C, ancer, 41, 2673
- Le Ray, 2012, Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study., Breast Cancer Res Treat, 135, 603, 10.1007/s10549-012-2198-y · DOI · Paper page
- OMeara, 2001, Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality., J Natl Cancer Inst, 93, 754, 10.1093/jnci/93.10.754 · DOI · Paper page
- Trinkaus, 2008, Should urogenital atrophy in breast cancer survivors be treated with topical estrogens O, ncologist, 13, 222, 10.1634/theoncologist.2007-0234 · DOI
- Kendall, 2006, Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors., Ann Oncol, 17, 584, 10.1093/annonc/mdj127 · DOI · Paper page
- Biglia, 2010, . Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study., Gynecol Endocrinol, 26, 404, 10.3109/09513591003632258 · DOI · Paper page
- 2012, Practice Bulletin No. 126. American College of Obstetricians and Gynecologists., Obstet Gynecol, 119, 666
Cited by
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M. S., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G. S., Biganzoli, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.010 · Cited by 1,369
Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Hormone therapy for postmenopausal women
Pinkerton, J. V. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp1714787 · Cited by 220
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2016-03
- Volume
- 127
- Issue
- 3
- Pages
- e93-e96
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W4244778899
- Cited by
- 177
- References
- 0
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Committee Opinion No. 659: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. https://app.cochat.ai/papers/10.1097/aog.0000000000001351
- The paper
- Committee Opinion No. 659: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. (2016). Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.